Clinical Trials Move Faster When Sites Get Paid On Time
Ivanna Rosendal Oshida
0:00 / 0:00
Clinical Trials Move Faster When Sites Get Paid On Time
2 просмотра · 2 дн. назад
Ivanna Rosendal Oshida
15 подписчиков
2 просмотра · 2 дн. назад
A clinical trial can have brilliant science and still stall for a painfully ordinary reason: the site does not get paid on time. We sit down with Patrick Mizer and Kevin Williams from LedgerRun to unpack why clinical trial site payments and contracts become a hidden bottleneck, how that pressure lands on research sites, and why sponsors and CROs only notice the “back office” when something breaks. If you care about trial timelines, study start-up, site experience, and getting therapies to patients faster, this conversation goes straight to the operational truth under the hype.
We dig into what makes site payments different from normal accounts payable: complex budgets, protocol amendments, mismatched data across systems like EDC, and the reality that many sites are not built like finance departments. Kevin explains the idea of staying off the critical path, and Patrick shares what surprised him most when he entered the space: people have historically been the glue holding together fragmented workflows. We also explore global clinical trials, where country specific financial norms add another layer of complexity that software must respect.
AI in healthcare is everywhere right now, so we get specific about what actually works. Patrick and Kevin walk through a human in the loop approach where AI reduces repetitive reconciliation work, while audit trails, permissions, and validation rules stay as strict as ever. We also discuss a compliance friendly architecture that keeps probabilistic AI outside the system of record, making it easier to explain, control, and govern in regulated environments. If you have ever wondered why change management beats features, you will recognise the tension between modern tools and “please let me keep emailing my invoice”.
Subscribe, share this with someone in clinical operations, and leave a review if it helps. What part of the clinical trial process feels most overdue for practical innovation?
________
Reach out to Ivanna Rosendal
Join the conversation on our LinkedIn page
Visit www.labtolives.com
Hosts
Alexander Booth
Chiara Chianese
Ivanna Rosendal Oshida
00:00 Welcome And Show Mission
01:00 Meet LedgerRun And The Hosts
04:51 AI Hype Versus Useful Execution
07:29 The Thesis Behind Site Payments
12:10 Why Paying Sites Gets Complicated
18:44 Adoption Friction And Meeting Sites
25:54 Human In The Loop AI Automation
27:18 Compliance Boundaries And Auditability
38:03 Quiz On Clinical Trial Costs
45:16 Key Takeaways And Where To Connect